• Join Today!

Become a member and connect with:

  • An Active Online Community
  • Articles and Advice on SCD
  • Help Understanding Clinical Trials
community advocates

Kehinde Salami, Bachelor of Science

Community Advocate
Founder and Director
Hay House, Border Cres
London, United Kingdom

Kehinde Salami, a sickle cell patient and a father to a sickle cell patient, is founder and director of The Sicklekan Sickle Cell Foundation Charity which is community/charitable organization raising awareness for sickle cell disease through various social media platforms.

He facilitate and produce presentations to universities, hospitals and other organizations teaching people about Sickle cell disease and how better to support individuals, children and families with the condition. He managed successfully get various celebrities to endorse and promote his charity over various media platforms. He and his organization is a part of an international consortium which includes policy leaders, pharmaceutical firms and other organizations in regards to improving better treatment and care for sickle cell patients.

He also has been featured on television, newspapers, blogs and the BBC which helped him in reaching to the wider community of patients living with the condition. Kehinde provides a platform for patients with sickle cell disease to have a voice and speak about their personal experiences.

expertly curated content related to this topic

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.